MAPT and neurodegenerative disease: As the most prevalent neurodegenerative disease, Alzheimer's disease (AD) progresses slowly, pathologically characterized by the loss of neurons, the deposition of amyloid‐beta (Aβ), and hyperphosphorylated tau (p‐tau), leading to progressive brain atrophy and cognitive decline.